(Q34197706)

31 July 2017

0 references

1 reference

title

Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). (English)

1 reference

31 July 2017

0 references

cardiovascular disease

1 reference

1 reference

Lee Hooper

4

0 references

author name string

Rod S Taylor

1

1 reference

31 July 2017

Kate E Ashton

2

1 reference

31 July 2017

Tiffany Moxham

3

1 reference

31 July 2017

Shah Ebrahim

5

1 reference

31 July 2017

publication date

6 July 2011

1 reference

Journal of Clinical Hypertension

31 July 2017

published in

1 reference

31 July 2017

volume

24

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

843-853

1 reference

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Reducing population salt intake worldwide: from evidence to implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Reducing dietary sodium: the case for caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

How should meta-regression analyses be undertaken and interpreted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Recruitment in the Hypertension Prevention trial. Hypertension Prevention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Baseline characteristics in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Quality assurance and monitoring in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Hypertension treated by salt restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Priority actions for the non-communicable disease crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Cost-effectiveness of interventions to reduce dietary salt intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Meta-analysis: principles and procedures

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Hypertension prevention trial: do 24-h food records capture usual eating behavior in a dietary change study?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Design, methods, and rationale in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Trials of hypertension prevention. Phase I design.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE)

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE)

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.115

7 January 2021

Identifiers

DOI

10.1038/AJH.2011.115

1 reference

31 July 2017

1 reference